The ClinicalTrials.gov results database addresses problems with the published literature including publication bias, incomplete reporting of outcome measures and adverse events, and lack of transparency regarding the prespecified trial protocol. Submissions to ClinicalTrials.gov must contain a complete set of minimum results data elements. Entries undergo a quality-control review process based on criteria drawn from fundamental scientific principles, legal requirements, and experience operating the database.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Zarin DA. The Culture of Trial Results Reporting at Academic Medical Centers. JAMA Intern Med. 2020;180(2):319–320. doi:10.1001/jamainternmed.2019.4200
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: